Media Room

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal antibody therapies for cancer. View online article For a licensed copy [CAL] of this article please... Read more

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with... Read more

Novotech Becomes Medidata Solutions’ Partner Medidata Solutions, a global eClinical provider, announced that Australian contract research organization (CRO) Novotech has joined Medidata’s ASPire to Win channel partner program. As Australia’s largest full-service Australian CRO with extensive operations across Asia, Novotech can now offer... Read more

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program Sydney-based Novotech Adds Global Services for Medidata Rave Clinical Trial Technology NEW YORK, N.Y. – June 1, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Australian... Read more

Novotech becomes Medidata’s first Australian partner Novotech (Australia) Pty Ltd has become the first Australian contract research organisation to partner with Medidata Solutions Inc and adopt the company’s clinical development software platform, in order to help it streamline the clinical research process for its customers. View Online Article For... Read more

Novotech joins Medidata programme Novotech has become the first Australia-based contract research organisation (CRO) to join Medidata Solutions’ ASPire to Win partner programme. Having joined the programme Novotech will use the Medidata Rave electronic data capture (EDC) and clinical data management (CDM) systems to streamline its trials. Asia... Read more

Novotech Joins Medidata ASPire To Win Channel Partner Program Australian contract research organization (CRO) Novotech has joined Medidata Solutions’ ‘ASPire to Win’ channel partner program. Medidata Solutions is a global provider of SaaS-based clinical development solutions. Novotech said that it can offer sponsors a full range... Read more

Asian CT growth benign The emergence of Asian countries as attractive places to conduct clinical trials will not negatively impact on Australia, an Indian expert said. Head of Clinical Operations Asia, for Novotech Australia, Lil Edis told the [ARCS - Association of Regulatory and Clinical Scientists] conference the number of clinical trials taking... Read more

India surges in trial activity Although more clinical trials are being held in Australia than India today, this will not be the case for much longer, Alek Safarian told Trials in Focus. Mr Safarian says Novotech currently runs trials in Australia, NZ, India, South Korea, Taiwan, Malaysia and Singapore in response to market demand which is progressively... Read more

Australian CRO Novotech Expands Asian Footprint Into Southeast Asia Australia’s largest independent contract research organisation, Sydney-based Novotech, is expanding its operations into four new Asian markets and establishing a management hub in Kuala Lumpur, Malaysia. “In keeping with our continued expansion in Asia, we are rolling... Read more

Novotech to Operate in Four More Asian Countries Continuing with its Asian growth plans, Australia-based contract research organization (CRO) Novotech http://www.novotech-cro.com is expanding its operations to include four more Asian countries: Malaysia, Singapore, Thailand and Philippines. Safarian is continuing with Novotech’s Asian expansion... Read more

Novotech expands in Asia with new Malaysian base Novotech says its new “management hub” in Kuala Lumpur, Malaysia will serve as a base for expansion in the booming Asia-Pacific contract research sector. The contract research organisation (CRO), which already has operations in India and Korea, said that, in addition to Malaysia, the facility... Read more

Novotech kicks off Dimebon trial Recruiting has begun for local sites in a Phase III international multi-centre study of the new Pfizer/Medivation Alzheimer’s hope Dimebon (Latrepirdine). CRO Novotech Which is running the CONCERT trial in Australia is looking to recruit patients with mild to moderate Alzheimer’s disease (AD) over... Read more

Interviewing Dr Roger Clarnette, from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study. Broadcast: 03/09/2009. Host: Geoff Hutchinson. About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s... Read more

Alzheimer’s Disease Trial Broadcast: 03/09/2009 Host: Geoff Hutchinson About this interview: Dr. Roger Clarenette from the McCusker Foundation, who is heading up the clincial trials in Perth for the CONCERT Study, trialing a new Alzheimer’s drug called dimebon. Dr Roger Clarnette talks about the drugs origins, the results from the... Read more

Biotech Trials plummet The number of clinical trials conducted for Australian biotechnology companies, usually by contract research organisations (CRO), has fallen by about 32 percent in the past year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1040 SHARETHIS.addEntry({ title: "BRW",... Read more

Novotech’s success: Instant Update Sydney-based CRO, Novotech, is trumpeting its success despite the tight economic environment, announcing it attracted $22 million worth of new projects in the year to March. The company said it had been awarded 23 new multi-centre phase II and III clinical studies across a variety of therapeutic areas including... Read more

Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion In keeping with its strategic focus on expanding in Asia, Australia-based contract research organization (CRO) Novotech has entered into a joint venture with ETI Klinical, a CRO based in Bangalore, India, and part of the Karle Group. Novotech already had, and will keep, its... Read more

Novotech Signs Joint Venture with Indian CRO ETI Klinical Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $600 million Indian multinational. The joint venture designed to service the growing demand for global... Read more

Novotech signs joint venture with Indian CRO ETI Klinical PVT Limited deal to drive more global clinical trials to India Novotech, a leading Australia based clinical research company, today announced it had entered into a strategic venture with ETI Klinical Pvt Ltd, part of the Karle Group of companies, a US $ 600 million Indian multinational. The... Read more

Aussie CRO Novotech Expands Asian Footprint With Indian ETI Joint Venture: An Interview With PharmAsia News The largest independent research organization in Australia, Sydney-based Novotech announced May 6 that it formed a joint venture with Bangalore-based ETI Klinical, which is part of the multinational Karle Group. With operations in Australia,... Read more

Novotech and ETI Ally to Harness Indian Clinical Research Opportunities Australia-based CRO, Novotech, and Indian CRO, ETI Klinical, are teaming up to help meet the growing international demand for clinical research in India. The joint venture aims to cover a wide range of therapeutic areas including oncology, respiratory disorders, infectious... Read more

Biotechs face bloodbath The listed Australian biotechnology sector expects a bloodbath, with industry heavyweights saying the struggles demonstrated by many smaller biotech stocks in February reporting season will leave many unsustainable by the end of the year. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote... Read more

AusBiotech 2008 – Australia’s Biotechnology Conference ‘Building a Bioeconomy’ Melbourne Convention Centre 26-29 October 2008 AusBiotech 2008 is the premier biotechnology conference for the Asia Pacific region. More than 1400 participants with over 500 Presidents, VPs, CEOs, Eos, MDs and CSOs from national companies will... Read more

Global CROs Expand in Asia Q: How do you see the opportunity for CROs in Australia? “We see tremendous growth opportunity. The local biotech industry is maturing and growing in complexity. There are far greater number of Australian and New Zealand biotechs in clinical trials now, than five years ago. Equally, overseas biotechs continue... Read more

Novotech ‘CRO of the Year’ NOVOTECH has confirmed its pre-eminence among Australian contract research organisations after taking out analyst house Frost & Sullivan’s award for the Australian CRO of the Year last week. The award is part of Frost & Sullivan’s recently announced Excellence in Healthcare Awards. For a licensed... Read more

Novotech wins CRO of the year Sydney’s Novotech has won another Frost & Sullivan award Sydney-headquartered contract research organization Novotech has won the Australian CRO of the Year award at the 2008 Frost & Sullivan Excellence in Healthcare Awards. Novotech won the same award in 2006. In the past year, Novotech, described by... Read more

Novotech Expanding in Asia-Pac, U.S. Having opened offices in both Hyderabad,India, and Seoul, Korea, recently, Novotech shared its plans for an ambitious expansion throughout the Asia- Pacific region. “Our intention is to essentially cover the Asia-Pacific region in the coming two or three years pretty thoroughly,” Alek Safarian, president... Read more

Monoclonal asthma trials kick off in Australia THE value of Australia as a clinical research site has again been reinforced, with private US biotech company KaloBios Pharmaceuticals launching a Phase 1/2 trial in Australia for the company’s engineered monoclonal antibody in persistent asthma. View online article » For a licensed copy [CAL]... Read more

Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late,involving Encorium Group, Holmes Biopharma and Novotech. Australian CRO Novotech has signalled that two new offices that it has been preparing in Hyderabad,India and Seoul, South Korea, will become operational... Read more

Novotech allergy clinical trial on national news Click here to view » SHARETHIS.addEntry({ title: "Channel Nine", url: "http://www.novotechmediaroom.com/2007/mediareport1025/" }); Read More →

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal... Read more

Prawns offer hayfever help VOLUNTEERS are wanted to trial a world-first treatment for hayfever made from prawn shells which researchers say is showing promising signs of success. Sydney-based company Novotech (http://www.novotech-cro.com/) is seeking hayfever sufferers aged 15 to 60 who are otherwise healthy to be volunteers to trial a nasal spray... Read more

Clinical Condition Ruth Beran spoke with Australian contract research organisations and found that there is strong demand for Australian clinical trials, both from within Australia and also from overseas. It comes as little surprise to Australian contract research organisations (CROs) that Australia was ranked as the number one clinical trial... Read more

Aussie CRO Novotech Raises Round For Asian Expansion Australian contract research organization Novotech Pty. has raised A$8 million ($7.3 million) in its first round of venture financing as it looks to expand into Asia. BioPacific Ventures of New Zealand and Co-Investor Capital Partners of Australia provided the funding. Alex Safarian, president... Read more

AusBiotech report: Novotech gets $8m boost Australian contract research organisation Novotech has received an $8 million injection of capital to back expansion plans in the US and Asia. The investment, from biotech venture firms BioPacificVentures and Co-Investor Capital Partners, will assist Novotech in its plans to open an office in India by... Read more

Novotech to invest Aus $8m to set up office in India Considering the opportunities in Asia, Novotech, thelargest Australian Contract Research Organization (CRO) will set up operations in Mumbai, India with an investment of Aus $8 million. The Mumbai office will be the first Asian operations for Novotech to be operational by the end of this year. For... Read more

Venture capital backs CRO expansion IT IS not just Australian research and development companies on the march in the biotech sector, according to Australian contract research organisation Novotech, which announced yesterday that the company has attracted major new venture capital to back its expansion plans. For a licensed copy [CAL] of this... Read more

Reef overcoming medical barriers The ocean – inparticular the Great Barrier Reef – is emerging as the planet’s richest source of new drugs and medical treatments, according to leading marine ecologists For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1014 SHARETHIS.addEntry({... Read more

The Daily News Novotech to announce new investors and expansion into Asia at AusBiotech 2007. Australian biotechs will soon have an Australian CRO based in Asia with Novotech planning to open a Mumbai office by the end 2007 with more to follow in the region. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote... Read more

Due to the recent economic slowdown in the west, the outsourcing business in life sciences, especially pharmaceuticals and biopharmaceutical business, has shown a surge. Consider this. Globally, since 2001, spending by drug sponsors on clinical research services has grown 15 percent annually, outpacing the 11 percent rate for overall spending... Read more

CEO, 60 Seconds The most enjoyable part of my job is…There are multiple: discussing new projects with clients, working with smart people, robust discussions at internal meetings with multiple points of view. For a licensed copy [CAL] of this article please email us at: team{at}onlinemediarooms.com Quote #1012 SHARETHIS.addEntry({ title:... Read more

Choosing The Right CRO Everything you ever wanted to know about choosing a contract research organization (CRO), but were afraid to ask—that’s basically what the folks at Sydney, Australia-based Novotech have created in their “Clinical Trials Checklist” for sponsors. Novotech, the biggest of the four Australia-based CROs, recently... Read more

Novotech releases updated “clinical trials checklist” At BIO 2007, Novotech, one of Australia’s largest owned contract research organization (CRO) with offices on the US east and west coasts, released its updated ‘Clinical Trials Checklist’ for CROs, biotech, pharma and VCs, to assist in the often challenging task... Read more

Novotech, the largest independent Australian owned contract research organization (CRO) and the only Australian CRO with offices in the USA, announced today that it is a winner in the Deloitte Fast 500 Asia Pacific 2006 Program The Program run by the leading global consultancy, is supported by the Deloitte Technology Fast 50 initiatives, which... Read more

Novotech Presents Checklist for CRO Partnering and Trials Selection in Australia & Asia at DIA 2006; Frost & Sullivan Asia Pacific Healthcare Best Practice Award 2006 Recipient Novotech, the largest Australian owned contract research organization (CRO) presented to the Drug Industry Association (DIA} annual conference 2006 this week, a... Read more

US biotech deal blazes Aussie trail AT just $4 million, it’s hardly the biggest biotech deal ever struck by an Australian company, but it’s an important first. That’s how the Sydney-based contract research organisation Novotech is describing the pediatrics-related clinical trial it will run for US biotech firm Skye-Pharma. For... Read more

Aust CROs tell of boom in clinical trials work Ruth Beran spoke with Australian contract research organisations and found that there is strong demand for Australian clinical trials, both from within Australia and also from overseas. It comes as little surprise to Australian contract research organisations (CROs) that Australia was ranked as... Read more

Australia ranked first as clinical trial location Australia is the number one location to conduct pharmaceutical clinical trials according to an international benchmarking study undertaken by The Economist Intelligence Unit. The study ranked Australia against six countries — the US, UK, Germany, Japan, Singapore and India — across arange... Read more

CRO Novotech springboards into US Australian CRO Novotech is setting up operations in the US to take advantage of the clinical trials opportunities offered there. “There is a natural ceiling in Australia for the size of clinical trials, due to our [small] population. We’re expanding offshore so that we can do larger trials — primarily... Read more

Trials without error: Australia’s clinical capabilities Australia’s clinical trial expertise may be the great undiscovered bargain for pharmas and biotechs from both the east and the western world. That sentiment comes from at least one high-profile international biotech observer — Richard Haiduck, a director of biotech investment... Read more

Aussies you’ll meet at BIO Australia is home to a thriving and dynamic biotechnology industry with a firm footing in the world-class research base found in the universities and research institutions ‘Down Under’. Within Australia’s biotechnology sector are numerous companies developing innovative new devices, drugs and therapeutics... Read more